Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Metastatic Breast Cancer|Metastatic Renal Cell Carcinoma
Interventions: DRUG: RAD001 + BEZ235
Sponsor: Novartis Pharmaceuticals